Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
March 20, 2026
Consortium-Based Patient and Public Involvement and Engagement for Long COVID Research: A Pirit-Focused Impact Evaluation of the PHOSP-COVID Study
Linzy Houchen-Wolloff, Joanna Bell, Rebecca Pritchard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
Jienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
The Lancet. Respiratory Medicine
|
July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Christopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
British Journal of Cancer
|
July 15, 2022
Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave
Beth Russell, Charlotte Moss, Maria Monroy-Iglesias, et al.
The Journal of Infection
|
March 2, 2024
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Gail Hayward, Ly-Mee Yu, Paul Little, et al.
The Journal of Infection
|
August 31, 2024
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Fd Richard Hobbs, Oghenekome A Gbinigie-Thompson, Milensu Shanyinde, et al.
American Heart Journal
|
May 16, 2023
PROTEUS Study: A Prospective Randomized Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiography
Gary Woodward, Mamta Bajre, Sanjeev Bhattacharyya, et al.
Lancet (London, England)
|
August 13, 2021
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Ly-Mee Yu, Mona Bafadhel, Jienchi Dorward, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 16, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial
May Ee Png, Victoria Harris, Jenna Grabey, et al.
Open Heart
|
May 27, 2024
Long COVID and cardiovascular disease: a prospective cohort study
Claire Alexandra Lawson, Alastair James Moss, Jayanth Ranjit Arnold, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
March 20, 2026
Consortium-Based Patient and Public Involvement and Engagement for Long COVID Research: A Pirit-Focused Impact Evaluation of the PHOSP-COVID Study
Linzy Houchen-Wolloff, Joanna Bell, Rebecca Pritchard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
Jienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
The Lancet. Respiratory Medicine
|
July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Christopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
British Journal of Cancer
|
July 15, 2022
Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave
Beth Russell, Charlotte Moss, Maria Monroy-Iglesias, et al.
The Journal of Infection
|
March 2, 2024
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Gail Hayward, Ly-Mee Yu, Paul Little, et al.
The Journal of Infection
|
August 31, 2024
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Fd Richard Hobbs, Oghenekome A Gbinigie-Thompson, Milensu Shanyinde, et al.
American Heart Journal
|
May 16, 2023
PROTEUS Study: A Prospective Randomized Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiography
Gary Woodward, Mamta Bajre, Sanjeev Bhattacharyya, et al.
Lancet (London, England)
|
August 13, 2021
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Ly-Mee Yu, Mona Bafadhel, Jienchi Dorward, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 16, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial
May Ee Png, Victoria Harris, Jenna Grabey, et al.
Open Heart
|
May 27, 2024
Long COVID and cardiovascular disease: a prospective cohort study
Claire Alexandra Lawson, Alastair James Moss, Jayanth Ranjit Arnold, et al.
Page
of 9